ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastrointestinal, Liver, Effusion, and Renal Safety Characterization in the BFORE Trial
By
ASCO 2022 Conference Coverage
FEATURING
Jorge Cortés
By
ASCO 2022 Conference Coverage
FEATURING
Jorge Cortés
13 views
June 15, 2022
Comments 0
Login to view comments.
Click here to Login
Leukemia